UK markets closed


NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.49+0.29 (+4.68%)
As of 12:57PM EDT. Market open.


2800 Discovery Drive
Orlando, FL 32826
United States
888 536 7271

IndustryMedical Devices
Full-time employees110

Key executives

NameTitlePayExercisedYear born
Mr. Nicholas T. CurtisCEO & Director888.59kN/A1956
Mr. Thomas R. Staab II, CPACFO & Sec.556.51kN/A1968
Mr. Alan B. ConnaughtonChief Operating Officer594.93kN/A1972
Ms. Kendra W. WongPrincipal Accounting OfficerN/AN/A1980
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Corporate governance

LENSAR, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.